(Q35089147)

6 August 2017

1 reference

title

Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment (English)

1 reference

6 August 2017

5

Fortunato Ciardiello

1 reference

6 August 2017

David Raben

1

1 reference

6 August 2017

Cataldo Bianco

2

1 reference

6 August 2017

Barb Helfrich

3

1 reference

6 August 2017

Elaine Weng

4

1 reference

6 August 2017

Paul Harari

6

1 reference

6 August 2017

publication date

1 August 2002

1 reference

Expert Review of Anticancer Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

461-471

1 reference

Molecular aspects of pancreatic cancer and future perspectives

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.4.461

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.4.461

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.4.461

Tyrosine kinase inhibitors in preclinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.4.461

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.4.461

Protein tyrosine kinase inhibitors as novel therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.4.461

21 January 2018

Identifiers

DOI

10.1586/14737140.2.4.461

1 reference

6 August 2017

1 reference